Colcrys: the dark side of market exclusivity (Morning Read)
After the FDA approved gout medicine Colcrys, the manufacturer brought a lawsuit seeking to remove any other versions of colchicine from the market and raised the price by a factor of more than 50, from $0.09 per pill to $4.85 per pill, according to a New England Journal of Medicine article quoted in db's Medical Rants blog.